1 unknown, 1 withdrawn. 1 Not applicable, 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 1 | Unknown 1 |
| Phase 2 | 1 | Withdrawn 1 |
Follow Lung Cancer Non-Small Cell Stage IIIB: new trials by email Literature Review of Lung Cancer Non-Small Cell Stage IIIB trials Research Report on Lung Cancer Non-Small Cell Stage IIIB
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Investigate Luveltamab Tazevibulin in Adults With Advanced or Metastatic Non-small Cell Lung Cancer Luveltamab tazevibulin - Lung Cancer, Lung Cancer Metastatic | Phase 2 | Withdrawn | Sutro Biopharma, Inc. | 2024-08-21 | 2025-08-22 | |
| Psychosocial eHealth in Advanced Lung Cancer E-health ecosystem of stepped psychosocial care, Usual psychosocial care - Lung Cancer, Nonsmall Cell, Stage IIIA, Lung Cancer Non-Small Cell Stage IIIB | Not applicable | Unknown | Institut Català d'Oncologia | 152 | 2022-11-15 | 2023-09-29 |
Carcinoma, Non-Small-Cell Lung (2) · Lung Neoplasms (2) · Behavior (1) · Patient Participation (1)
Bronchial Neoplasms (2) · Carcinoma, Bronchogenic (2) · Lung Diseases (2) · Neoplasms (2) · Neoplasms by Site (2) · Respiratory Tract Diseases (2) · Respiratory Tract Neoplasms (2) · Thoracic Neoplasms (2) · Health Behavior (1) · Patient Acceptance of Health Care (1) · Treatment Adherence and Compliance (1)
Institut Català d'Oncologia (1) · Sutro Biopharma, Inc. (1)
Spain (1) · United States (1)